SCHEMBL6312381

SCHEMBL6312381

CN(C)CC=NC(=O)C=Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ GLA P06280 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ MAPT P10636 3/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ HDAC3 O15379 2/20 0.46
▸ HDAC4 P56524 2/20 0.46
▸ HDAC1 Q13547 2/20 0.46
▸ HDAC2 Q92769 2/20 0.46
▸ HDAC8 Q9BY41 2/20 0.46
▸ HDAC6 Q9UBN7 2/20 0.46
▸ PLIN1 O60240 2/20 0.46
▸ LMNA P02545 2/20 0.46
▸ RECQL P46063 2/20 0.46
▸ PLIN5 Q00G26 2/20 0.46
▸ ABHD5 Q8WTS1 2/20 0.46
▸ TNKS O95271 1/20 0.46
▸ HCAR2 Q8TDS4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6313240 0.79 GLA (0.52) NPC1L3MBTL1GLATDP1MAPT
SCHEMBL6313245 0.79 GLA (0.52) NPC1L3MBTL1GLATDP1MAPT
SCHEMBL27560284 0.74 MAPT (0.57) NPC1GLATDP1MAPTALDH1A1
SCHEMBL13268552 0.73 EGFR (0.42) NPC1MAPTALDH1A1RECQLCYP1A2
SCHEMBL15263885 0.73 EGFR (0.42) NPC1MAPTALDH1A1RECQLCYP1A2
SCHEMBL11476908 0.72 TDP1 (0.61) NPC1L3MBTL1GLATDP1MAPT
SCHEMBL11476916 0.72 TDP1 (0.61) NPC1L3MBTL1GLATDP1MAPT
SCHEMBL4029202 0.72 MAPT (0.64) NPC1L3MBTL1GLATDP1MAPT
SCHEMBL4023735 0.72 MAPT (0.64) NPC1L3MBTL1GLATDP1MAPT
SCHEMBL6313483 0.71 MAPT (0.53) NPC1GLATDP1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6956049-B1 Methods of modulating processes mediated by excitatory amino acid receptors MERCK & CO., INC. (US) 2005-10-18 — — US disclosed
EP-1214303-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF Merck & Co., Inc. (US) 2002-06-19 — — EP disclosed
WO-2001016121-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF MERCK & CO., INC. (US) 2001-03-08 — — WO disclosed
Send feedback